STERIS's SWOT analysis: infection prevention leader's stock poised for growth
STERIS plc (NYSE:STE), a leading provider of infection prevention and procedural products and services with a market capitalization of $21.6 billion, has been navigating a dynamic healthcare landscape ...
Cigna (NYSE:CI) Surprises With Q4 Sales
Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q4 CY2024, with sales up 28.4% year on ...
Lifco projects 14% dividend increase amid mixed performance across business segments
Lifco continues to prioritize selective acquisitions, targeting high-quality companies to sustain long-term growth. The company remains cautious about inventory levels, with efforts to gradually ...
Should Utah remove fluoride from its water? House committee overwhelmingly says ‘yes.’
A House committee voted 10-3 to approve a bill to remove fluoride from all water systems in the state, arguing people should ...
Lifco AB: Year-end report 2024
DecemberNet sales increased 6.9 per cent to SEK 26,137 (24,454) million. Organically, net sales declined -0.5 per cent.EBITA increased 4.5 per cent to SEK 5,917 (5,664) million.The ...
What Analysts Are Saying About Henry Schein Stock
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
The Canadian Press on MSN10h
Canadian small businesses working to fend off effects of tariffs, despite reprieve
U.S. President Donald Trump might have delayed 25 per cent tariffs on Canadian goods for a month, but Tyler Pubben isn't ...
American Association of Individual Investors6d
Which Is a Better Investment, Inari Medical, Inc. or DENTSPLY SIRONA Inc. Stock?
Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Lifco reports higher Q4 sales and profit despite weakness in demolition and tools
“Lifco’s primary goal is to increase its earnings every year through organic growth and acquisitions,” said Per Waldemarson, chief executive at Lifco in a statement. The board also proposed a dividend ...
Zimvie (ZIMV) Slid on Acquisition Rumors
Summers Value Partners, an investment management company, released its fourth quarter 2024 investor letter. A copy of the ...
Lifco AB (STU:1L30) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Dividend Increase ...
Lifco AB (STU:1L30) reports robust Q4 2024 performance with an 11% sales increase and a proposed 14% dividend hike, despite facing challenges in certain divisions.
Becker's ASC1d
ASCs in 2024: A Year in Review
The ambulatory surgery center (ASC) industry experienced another transformative year in 2024, marked by accelerated growth, evolving case complexity, and continued regulatory shifts. Strategic ...